seal  Purdue News
____

January 20, 2004

Fat cells fight disease, Purdue University researchers find

WEST LAFAYETTE, Ind. - Fat cells, commonly blamed for a number of diseases, also may aid in the body's defense against illnesses such as diabetes and cancer, according to Purdue University researchers.

Spurlock and Kolapo Ajuwon
Download photo - caption below

Rather than contributing to disease, fat cells, or adipocytes (pronounced ah-dip-poe-sights), normally function as part of the immune system and help control lipid accumulation, so they actually may benefit human health, said Michael Spurlock, animal sciences professor.

"Adipocytes can be functional and beneficial without creating obesity," Spurlock said. "The key is that we want plenty of adipocytes to meet whatever immunological and endocrinological needs they fulfill, but we don't want them to overaccumulate lipid."

In the January issue of The American Journal of Physiology, Spurlock and Kolapo Ajuwon, both of the Department of Animal Sciences and the Comparative Medicine Program, report that pig fat cells respond to infections by producing hormone-like proteins that regulate certain aspects of the body's immune response.

"This is additional evidence that fat cells behave in many ways as immune cells," Spurlock said. "It also is the first evidence that adipocyte cells respond directly to bacterial toxins like classical immune cells."

To produce this infection-fighting response, Ajuwon, a doctoral student, performed experiments exposing fat cells to interferon-gamma, a small protein produced by infection-fighting T-cells. This caused the adipocytes to produce hormone-like proteins, called cytokines.

"Our research documents a pathway by which the adipocytes participate in the immune response," Spurlock said. "We have very clearly shown that interferon-gamma is increasing expression of cytokines in pig fat cells."

In another part of the study, the researchers found that a molecule, or ligand, binds to molecules on the outside of pig fat cells incubated in a laboratory dish. In this case the ligand is an inflammatory molecule called LPS. This binding with the receptor molecule on the pig fat cell, like a key in a lock, signals fat cells to produce more of another hormone-like cytokine.

The researchers believe that this is similar to what happens in humans since some pig breeds show marked similarity in cardiovascular disease, hyperglycemia and insulin resistance, Spurlock said. The study's findings that the LPS ligand and interferon-gamma regulate production of cytokines that impact both energy metabolism and immune function are significant in studying human diseases, including cancer and diabetes.

The factor in the fat tissue that is linked to diseases is the amount of lipid, also known as fatty acid or tricylglycerol, in the adipocytes, he said. As adipocytes accumulate excess lipid, their normal function is distorted and they produce too much of some biochemicals and not enough of others. These abnormalities can culminate in disease.

"For a long time, we have looked for the link between the immune system, obesity and insulin resistance," Spurlock said. "The fact that fat cells actually promote or secrete factors, such as the cytokine interleukin-6, may be fundamentally linked to insulin resistance in diabetes. This makes adipocytes very important cells."

People with Type II diabetes produce insulin in their pancreas, but the insulin can't control their glucose levels. Adipocytes normally produce factors that promote insulin regulation of glucose levels, but these factors don't function properly when obesity is involved.

Spurlock and his research team now want to determine other factors, such as certain classes of fatty acids, that will activate or suppress the LPS receptor.

"We know there are non-infectious ligands that activate the receptor, so we want to know what they are," he said. "If we can discover these regulators, then we might be able to find a way to manipulate the receptors and immune pathways to regulate the body's energy metabolism and apply that to diabetes and cancer."

The other researchers involved in the study are doctoral student Sheila Jacobi and research associate Joanne Kuske, both of the Purdue Department of Animal Sciences and the Comparative Medicine Program. The program is a collaboration of Purdue's Department of Animal Sciences, School of Veterinary Medicine and Indiana University School of Medicine with initial funding from the Indiana 21st Century Research and Technology Fund.

Writer: Susan A. Steeves, (765) 496-7481, ssteeves@purdue.edu

Source: Michael Spurlock, (765) 494-4820, spurloc0@purdue.edu

Ag Communications: (765) 494-2722; Beth Forbes, bforbes@aes.purdue.edu
Agriculture News Page

 

PHOTO CAPTION:
Purdue researchers have determined that fat cells in humans defend against biochemical processes involved in illnesses such as diabetes and cancer. The research team is headed by Michael Spurlock (left), professor of animal sciences, and Kolapo Ajuwon, a doctoral student. (Purdue Agricultural Communications photo/Tom Campbell)

A publication-quality photo is available at http://ftp.purdue.edu/pub/uns/+2004/spurlock.fatcells.jpeg.

 


ABSTRACT

Interleukin-6 and Interleukin-15 are Selectively Regulated by Lipopolysaccharide and Interferon-γ in Primary Pig Adipocytes

Kolapo M. Ajuwon, Sheila K. Jacobi, Joanne L. Kuske and Michael E. Spurlock – Department of Animal Sciences, Comparative Medicine Program Purdue University, West Lafayette, IN

3T3-L1 adipocytes express the lipopolysaccharide (LPS) receptor, and respond to direct stimulation with the antigen by increasing the expression of inflammatory mediators. Activation of this receptor by its ligand in the macrophage causes the activation and translocation of nuclear factor kappa-B (NFkB) to the nucleus where it regulates the expression of proinflammatory cytokines and other target genes. We investigated whether LPS could stimulate NFkB translocation in primary pig adipocytes and regulate the expression and secretion of TNF-α and IL-6. LPS clearly induced the nuclear translocation of NFkB, and also up-regulated (P < 0.05) the mRNA expression and secretion of IL-6 into the culture medium. An induction of TNF-α expression by LPS was not detected, but with extended incubation (8 hours), there was a modest increase (P < 0.09) in the media concentration of this cytokine. Inhibition of either ERK1/2, PKC, or the inhibitory G protein (Gi) with U0126, Bisindolylmaleimide HCl, and pertussis toxin, respectively, blocked (P < 0.05) the increase in IL-6 expression caused by LPS. Because LPS administration in vivo increases circulating concentrations of IFN-γ, and because this cytokine also regulates multiple immune modulators in the adipocyte, we also determined whether IFN-γ regulates cytokine expression in primary adipocytes. Although the expression of IL-6 and TNF-α were unresponsive to IFN-γ, the expression of IL-15 was markedly up-regulated (P < 0.01). Furthermore, the induction of IL-15 expression by IFN-γ was blocked by inhibition of PKC. These data indicate that NFkB is responsive to LPS in the adipocyte, and also identify key mediators of LPS-induced IL-6 expression. In addition, we provide novel evidence that IFN-γ targets the adipocyte to induce IL-15 expression, thus indicating a possible role for the adipocyte in the regulation of T-cell function and muscle metabolism during the innate immune response.


* To the Purdue News and Photos Page